Skip to Content
Morningstar

Global X Genomics & Biotechnology ETF GNOM

Morningstar Medalist Rating
Medalist Rating as of | See Global X Investment Hub

Morningstar’s Analysis GNOM

Will GNOM outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable GNOM’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the GNOM management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of GNOM’s parent organization’s priorities and whether they’re in line with investors’ interests.

A drop in its Process Pillar rating is the primary driver of Global X Genomics& Biotechnology ETF's downgrade to a Morningstar Medalist Rating of Negative from Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GNOM

More GNOM Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 46.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Alnylam Pharmaceuticals Inc

6.66 6.3 Mil
Healthcare

Avidity Biosciences Inc Ordinary Shares

5.28 5.0 Mil
Healthcare

Sarepta Therapeutics Inc

4.80 4.5 Mil
Healthcare

Natera Inc

4.68 4.4 Mil
Healthcare

Bio-Techne Corp

4.34 4.1 Mil
Healthcare

Arrowhead Pharmaceuticals Inc

4.19 3.9 Mil
Healthcare

Moderna Inc

4.16 3.9 Mil
Healthcare

Myriad Genetics Inc

4.07 3.8 Mil
Healthcare

Intellia Therapeutics Inc

3.98 3.8 Mil
Healthcare

Legend Biotech Corp ADR

3.83 3.6 Mil
Healthcare